Filing Details
- Accession Number:
- 0000886163-13-000085
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-20 19:44:35
- Reporting Period:
- 2013-08-16
- Filing Date:
- 2013-08-20
- Accepted Time:
- 2013-08-20 18:44:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1392266 | S Charles Berkman | 11119 North Torrey Pines Road, Suite 200 La Jolla CA 92037 | Vp, Gen. Counsel & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-08-16 | 14,583 | $9.96 | 28,227 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-08-16 | 14,583 | $42.63 | 13,644 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-08-19 | 4,284 | $10.05 | 17,928 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right to buy) | Disposition | 2013-08-19 | 4,284 | $0.00 | 4,284 | $10.05 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-08-16 | 14,583 | $0.00 | 14,583 | $9.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,937 | 2021-02-17 | No | 4 | M | Direct | |
| 2,083 | 2020-02-15 | No | 4 | M | Direct |
Footnotes
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/17/11.
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/15/10.
Billionaire Hedge Funds
